Help us advance care for multiple myeloma
Find out more about the LINKER clinical studies
Are you considering a clinical research study as an option for multiple myeloma (MM)?
This website provides information about the LINKER studies for people with MM. These studies aim to test the safety, tolerability (how your body reacts), and efficacy (reduction in the number of cancer cells in your blood) of an investigational drug in treating MM. The study drug is called “investigational” as it has not yet been approved for use outside of this study.
Clinical studies are essential to investigating potential treatments. Living with MM, you may feel that you have enough to do without committing to a clinical study. However, everyone involved in this clinical study plays an important role in increasing our understanding of MM, which may help others with this condition in the future. Every treatment that exists today is available because of people who took part in research.
English (United States) 
Japanese 
Spanish (United States) 
English (UK) 
English (Australia) 
Spanish (Chile)